Protagonist Therapeutics EV/EBITDA Ratio 2011-2026 | PTGX

Annual EV/EBITDA Ratio Protagonist Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-10.1	-10.7	-2.14	-2.36	-7.54	-3.13	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.14	-10.7	-6

EV/EBITDA Ratio of other stocks in the Biotechnology industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.591	-	2.43 %	$ 254 M	Germany
Grifols, S.A. GRFS	13.7	$ 7.72	1.85 %	$ 6.83 B	Spain
Amphastar Pharmaceuticals AMPH	17.3	$ 19.68	0.92 %	$ 920 M	USA
Amarin Corporation plc AMRN	123	$ 14.5	0.03 %	$ 6.02 B	Irlanda
GlaxoSmithKline plc GSK	33.1	$ 52.37	1.02 %	$ 173 B	Britain
I-Mab IMAB	595	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	10.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	4.22 K	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	-15.7	$ 221.59	-0.13 %	$ 5 B	Danmark
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Autolus Therapeutics plc AUTL	-1.38	$ 1.39	1.46 %	$ 355 M	Britain
Midatech Pharma plc MTP	0.796	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.42	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.546	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	1.84	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	4.4	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-1.85	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	0.777	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-3.38	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-0.0369	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	1.8	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14	-	-	-	Russia
Heron Therapeutics HRTX	-4.31	$ 0.81	3.74 %	$ 135 M	USA
Avenue Therapeutics ATXI	0.871	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-1.32	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-3.39	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-82.4	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	0.785	-	-	$ 7.46 M	Israel
Benitec Biopharma BNTC	0.734	$ 11.05	0.64 %	$ 455 M	USA
Atreca BCEL	-2.76	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	8	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-208	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-7.96	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-6.7	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-0.721	-	-	$ 3.74 B	USA
Immunovant IMVT	918	$ 24.1	4.85 %	$ 3.65 B	USA
Bellerophon Therapeutics BLPH	0.0235	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	24	$ 90.36	-0.47 %	$ 17.6 B	USA
InMed Pharmaceuticals INM	14.6	$ 0.74	-9.75 %	$ 1.81 M	Canada
INmune Bio INMB	-3.64	$ 1.17	-0.43 %	$ 21 M	USA
Checkpoint Therapeutics CKPT	-0.833	-	-	$ 169 M	USA
Clovis Oncology CLVS	-3.86	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-4.27	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-7.74	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	-7.07	$ 2.13	1.91 %	$ 199 M	Israel
Innate Pharma S.A. IPHA	-6.65	$ 1.35	15.38 %	$ 235 M	France
Akero Therapeutics AKRO	-4.64	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-3.41	$ 4.43	4.6 %	$ 735 M	Canada
Inventiva S.A. IVA	-9.77	$ 6.1	5.5 %	$ 138 M	France
Akouos AKUS	-1.13	-	0.23 %	$ 488 M	USA